Head & Neck Oncology Session
GI Cancer Session
Immuno Oncology Session
Oncology Nutrition Session
Imaging Session
Live Surgical Session

Head & Neck Session

08:30 – 10:30

Session 1 – Thyroid and Parathyroid
Pankaj Chaturvedi, India | Manjiri Gupte, United Arab Emirates

08:30 – 08:50

Management of Tracheal Compression in Thyroid Surgery
Shaik Irfan Basha, United Arab Emirates

08:50 – 09:10

Surgery for Advanced Thyroid Cancer
Alain Sabri, United Arab Emirates

09:10 – 10:30

Panel Discussion: Thyroid and Parathyroid
Aly Bernard Khalil, United Arab Emirates | Shaik Irfan Basha, United Arab Emirates | Yogesh More, United Arab Emirates | Ashok Shaha, USA | Asif Moin, United Arab Emirates | Carmelo Barbaccia, United Arab Emirates | Mohamed Al Ali, United Arab Emirates

10:45 – 12:20

Session 2 – Pearls of Wisdom
Yogesh More, United Arab Emirates | Mohamed Al Ali, United Arab Emirates

10:45 – 11:05

Pediatric Head Neck Lesions
Safeena Kherani, United Arab Emirates

11:05 – 11:25

Salivary Gland Surgery
Mahdi Shkoukani, United Arab Emirates

11:25 – 11:45

Precision Oncology Treatment in UAE for Patients With RET-Driven Thyroid cancers – Supported By Lilly
Jonathan Wadsley, United Kingdom

11:45 – 12:05

The Expanding Algorithm of R/M SCCHN Management – Supported By Merck Serono
Fadi Farhat, Lebanon

12:05 – 12:20

Question and Answer

13:20 – 16:20

Session 3 – Case Based Discussion
Akshat Malik, India | Muhammad Azad, Bangladesh

13:20 – 14:20

Case Based Discussion on Head Neck Squamous Cell Carcinoma
Sarbani Ghosh Laskar, India | Supreeta Arya, India | Prabhash Kumar, India | Carmelo Barbaccia, United Arab Emirates | Sadir Al Rawi, United Arab Emirates | Johann Kluge, South Africa | Mohammed Al Falasi, United Arab Emirates | Pankaj Chaturvedi, India

14:20 – 15:20

Case Based Discussion on Skull Base Tumors
Prathamesh Pai, India | Abhishek Mahajan, India | Dan Fliss, Israel | Ehab Hanna, USA | Deepa Nair, India

15:20 – 16:20

Case Based Discussion on Salivary Gland Tumors
Devendra Chaukar, India | Salma Al Sheibani, Oman | Vidisha Tuljapurkar, India | Mohammad Razif, Malaysia | Abhishek Vaidya, India | Aseem Mishra, India

16:35 – 17:45

Session 4 – Free Papers
Ameya Asarkar, USA | Manish Mair, United Kingdom

16:35 – 16:50

Local Extent of Tumor Predicts Outcome over and above the T Staging of Tongue Cancer: A Tool to Identify Aggressive Disease within the same T Stage

16:50 – 17:05

Role of S100P as a New Prognostic Marker in Women with Metastatic Breast Cancer and its Correlation with BCL2 and BAX Expression

17:05 – 17:20

Association of miRNA191 Expression Levels and APC Gene Methylation Status with Survival Outcome of Breast Cancer Patients

17:20 – 17:35

Question and Answer

17:35 – 17:45

Closing Remarks
Pankaj Chaturvedi, India
 

GI Cancer

09:00 – 09:05

Welcome Remarks
Bhawana Sirohi, India

09:05 – 10:20

Session 1: Year in Review for GI Cancers 2021 – 2022
Zakir Mohamed, United Arab Emirates | Maroun El Khoury, United Arab Emirates | Nouri Bennini, United Arab Emirates

09:05 – 09:25

Clinical Utility of ctDNA for CRC and Immunotherapy Response Monitoring – Supported By Natera
Suayib Yalcin, Turkiye

09:25 – 09:40

Colorectal Cancers
Leonard Saltz, USA

09:40 – 09:55

Esophago-Gastric Cancers
Viraj Lavingia, India

09:55 – 10:10

Hepato-Pancreato-Biliary Cancers
Priya Tiwari, India

10:10 – 10:20

Q & A

10:35 – 12:00

Session 2: Actionable Targets and Clinical Evidence in GI Cancers and Challenging Cases
Khalid Balaraj, United Arab Emirates | Sanjay Sharma, India

10:35 – 10:55

Novel Targets in GI Cancer: Where are we in 2021?
Milind Javle, India

10:55 – 11:15

Exploring the Evidence in 1L Treatment of mCRC- Supported By Merck
Mario Scartozzi, Italy

11:15 – 11:30

Current & “Under-Investigation” Roles of Immune Checkpoint Inhibitors in MSI-H & MSS Metastatic CRC
Deborah Mukherji, Lebanon

11:30 – 12:00

GI Cancer Multidisciplinary Tumor Board: Challenging Cases
Bhawana Sirohi, India | Shona Nag, India | Tarek Dufan, United Arab Emirates | Ashwathy Mathew, India | Ramanujam Singarachari, United Arab Emirates | Anita Ramesh, India | Sabita Jiwnani, India | Sanjay Sharma, India | Sonia Otsmane, United Arab Emirates | Nouri Bennini, United Arab Emirates

12:00 – 12:20

Updates in Chemotherapy Induced Nausea & Vomiting (CINV) Management – Supported by Mundipharma
Emad Anwar Dawoud, United Arab Emirates

12:00 – 13:05

Session 3: De-Escalating /Escalating Treatments in GI Cancers
Diaeddine Ahmad Trad, United Arab Emirates

12:20 – 12:35

Total Neoadjuvant Therapy in Rectal Cancer : Times are Changing
Sharlene Gill, Canada

12:35 – 12:50

Selecting Patients for Non-Operative Management of Rectal Cancers
Michael Buckstein, USA

12:50 – 13:05

Evidence Based HIPEC in GI Cancers
Manish Bhandare, India

13:05 – 13:10

Closing Remarks
Bhawana Sirohi, India
 

Immuno Oncology

13:30 – 13:35

Opening Remarks
Tobias Arkenau, United Kingdom

13:35 – 13:50

Integrating Immunotherapy in Upper GI Malignancies: Where are we in 2021?
Tobias Arkenau, United Kingdom

13:50 – 14:20

IO therapies for Advanced HER 2 negative Gastric cancer : Where do we stand? – Supported By BMS
Fathi Al Azribi, United Arab Emirates

14:20 – 14:35

Immunotherapy in Melanoma: Bringing it into the Earlier Stage Setting
Jeffrey Weber, USA

14:35 – 14:50

Immunotherapy in TNBC: Have we made History?
Javier Cortes, Spain

14:50 – 15:10

Evolving Landscape in TNBC Management – Supported By MSD
Shaheenah Dawood, United Arab Emirates

15:10 – 15:25

GU Malignances and Immunotherapy: Where are we in 2021?
Deborah Mukherji, Lebanon

15:25 – 15:40

Combination Immunotherapy: Where are we in 2021?
Solange Peters, Switzerland

15:40 – 16:00

Early Lung Cancer and New Data Outcomes – Supported by Roche
Fathi Al Azribi, United Arab Emirates

16:00 – 16:15

Incorporating Vaccine Therapy as Therapeutic Strategy: The Wave of the Future?
Giuseppe Curigliano, Spain

16:15 – 17:00

Round Table Discussion: Using Immunotherapy in Every day Clinical Practice: Challenges & Opportunities
Tobias Arkenau, United Kingdom | Bassim Al Bahrani, Oman | Deborah Mukherji, Lebanon | Fathi Al Azribi, United Arab Emirates | Diaeddine Ahmad Trad, United Arab Emirates | Mohanad Diab, United Arab Emirates | Solange Peters, Switzerland | Giuseppe Curigliano, Spain | Bhawana Sirohi, India

17:00 – 17:05

Closing Remarks
Tobias Arkenau, United Kingdom
 

Oncology Nutrition Session

09:00 – 09:10

Opening Remarks
Wafaa Helmi Ayesh, United Arab Emirates

09:10 – 09:40

Role of Dietary and Lifestyle Habits in Breast Cancer: An Opportunity for Prevention
Moez Al Islam Faris, United Arab Emirates

09:40 – 10:10

Breast Cancer and Nutrition Research among Arab Countries: Gaps and Opportunities
Farah Naja, United Arab Emirates

10:10 – 10:40

Physical Activity and Immunity a Positive Relationship
Osama Alalla, United Arab Emirates

10:40 – 10:50

Closing Remarks
Wafaa Helmi Ayesh, United Arab Emirates
 

Imaging Session

13:30 – 13:40

Opening Remarks
Rolf Hartlung, United Arab Emirates

13:40 – 14:30

Breast Imaging – Case Discussions
Millicent Bello, United Arab Emirates | Dorria Salem, Egypt | Bhawna Dev, India | Yee Ting Sim, United Arab Emirates | Palak Popat, India | Mahira Yunus, United Arab Emirates

14:30 – 14:50

Challenges with Imaging and Immunotherapy
Jaikishan P Mordani, United Arab Emirates | Masood Ali, United Arab Emirates

14:50 – 15:10

Artificial Intelligence and Imaging- Where we stand?
Abhishek Mahajan, India

15:10 – 15:50

The Post-Operative Neck Case Discussions
Abhishek Mahajan, India | Anil D’Cruz, India | Abdul Aleem, United Arab Emirates | Nuri Arslan, Turkiye | Patrizia Porcu, United Arab Emirates

16:05 – 16:35

Prostate, PIRADS and Case Discussions
Lutfi Kurban, United Arab Emirates | Mudhar Hassan, United Arab Emirates | Reinhold Posch Zimmermann, United Arab Emirates | Abdul Samad Punekar, United Arab Emirates | Rana Mahmood, United Arab Emirates

16:35 – 17:35

Case Discussion : 1. Colo-Rectal Liver Metastases | 2. Hepato-Cellular Carcinoma
Tugsan Balli, Turkiye | Massimo Malago, United Kingdom | Okan Akhan, Turkiye | Hemant Vadeyar, United Arab Emirates | Zergham Zia, Saudi Arabia | Mahmoud Tabbal, United Arab Emirates | Kaiser Raja, United Arab Emirates

17:35 – 17:45

Closing Remarks
Rolf Hartlung, United Arab Emirates

Live Surgical

08:00 – 16:00

Live Surgical Session
Rolf Hartlung, United Arab Emirates

08:00 – 16:00

OPERATION THEATRE 1 : Breast Conserving Surgery (BCS)
Rajendra Badwe, India

08:00 – 16:00

OPERATION THEATRE 1 : Whipple Procedure with SMA First Approach
Vikram Chaudhari, India | Shailesh Shrikhande, India

08:00 – 16:00

OPERATION THEATRE 2 : Total Thyroidectomy with Central Compartment Clearance
Prathamesh Pai, India

08:00 – 16:00

OPERATION THEATRE 2 : Minimally Invasive Urologic Cancer Surgery
Mahendra Pal, India | Ganesh Bakshi, India